journal article
Open Access
Oct 01, 2021
Transplantation for pulmonary arterial hypertension with congenital heart disease: Impact on outcomes of the current therapeutic approach including a high-priority allocation program
Topics
No keywords indexed for this article. Browse by subject →
References
44
[1]
Hopkins "Comparison of the hemodynamics and survival of adults with severe primary pulmonary hypertension or Eisenmenger syndrome" J Heart Lung Transplant. (1996)
[2]
Dimopoulos "Improved survival among patients with Eisenmenger syndrome receiving advanced therapy for pulmonary arterial hypertension" Circulation. (2010) 10.1161/circulationaha.109.883876
[3]
Diller "Current therapy and outcome of Eisenmenger syndrome: data of the German National Register for congenital heart defects" Eur Heart J. (2016) 10.1093/eurheartj/ehv743
[4]
Kempny "Predictors of death in contemporary adult patients with Eisenmenger syndrome: a multicentre study" Circulation. (2017) 10.1161/circulationaha.116.023033
[5]
Hascoët "Long-term outcomes of pulmonary arterial hypertension under specific drug therapy in Eisenmenger syndrome" J Heart Lung Transplant. (2017) 10.1016/j.healun.2016.10.006
[6]
Hjortshøj "Past and current cause-specific mortality in Eisenmenger syndrome" Eur Heart J. (2017) 10.1093/eurheartj/ehx201
[7]
Galiè "Bosentan therapy in patients with Eisenmenger syndrome: a multicenter, double-blind, randomized, placebo-controlled study" Circulation. (2006) 10.1161/circulationaha.106.630715
[8]
Hascoet "Outcome of adults with Eisenmenger syndrome treated with drugs specific to pulmonary arterial hypertension: a French multicentre study" Arch Cardiovasc Dis. (2017) 10.1016/j.acvd.2017.01.006
[9]
Arnott "Pulmonary vasodilator therapy is associated with greater survival in Eisenmenger syndrome" Heart. (2018) 10.1136/heartjnl-2017-311876
[10]
Adriaenssens "Advanced therapy may delay the need for transplantation in patients with the Eisenmenger syndrome" Eur Heart J. (2006) 10.1093/eurheartj/ehl017
[11]
Ross "Transplantation and mechanical circulatory support in congenital heart disease: a scientific statement from the American Heart Association" Circulation. (2016) 10.1161/cir.0000000000000353
[12]
Kaemmerer "Pulmonary hypertension in adults with congenital heart disease: updated recommendations from the Cologne Consensus Conference 2018" Int J Cardiol. (2018) 10.1016/j.ijcard.2018.08.078
[13]
Lewis "When should adult congenital heart disease patients be considered for transplant and deciding which organs to transplant" Prog Cardiovasc Dis. (2018) 10.1016/j.pcad.2018.09.004
[14]
Stoica "Heart-lung transplantation for Eisenmenger syndrome: early and long-term results" Ann Thorac Surg. (2001) 10.1016/s0003-4975(01)03099-5
[15]
Waddell "Heart-lung or lung transplantation for Eisenmenger syndrome" J Heart Lung Transplant. (2002) 10.1016/s1053-2498(01)00420-x
[16]
Christie "The Registry of the International Society for Heart and Lung Transplantation: 29th adult lung and heart-lung transplant report-2012" J Heart Lung Transplant. (2012) 10.1016/j.healun.2012.08.004
[17]
Hjortshøj "Outcome after heart-lung or lung transplantation in patients with Eisenmenger syndrome" Heart. (2020) 10.1136/heartjnl-2019-315345
[18]
Savale "Impact of high-priority allocation on lung and heart-lung transplantation for pulmonary hypertension" Ann Thorac Surg. (2017) 10.1016/j.athoracsur.2017.02.034
[19]
Galie Eur Heart J. (2016) 10.1093/eurheartj/ehv317
[20]
Fadel "Long-term outcome of double-lung and heart-lung transplantation for pulmonary hypertension: a comparative retrospective study of 219 patients" Eur J Cardiothorac Surg. (2010) 10.1016/j.ejcts.2010.02.039
[21]
Dorent "New French heart allocation system: Comparison with Eurotransplant and US allocation systems" Am J Transplant. (2020) 10.1111/ajt.15816
[22]
Weill "A consensus document for the selection of lung transplant candidates: 2014–an update from the Pulmonary Transplantation Council of the International Society for Heart and Lung Transplantation" J Heart Lung Transplant. (2015) 10.1016/j.healun.2014.06.014
[23]
L’Agence de la biomedecine. Procedures d’application des regles de repartition et d’attribution des greffons preleves sur personne decedee. www.agence-biomedecine.fr/IMG/pdf/regles_repartition_organes_decembre2013.pdf. Accessed December 1, 2016.
[24]
Simonneau "Updated clinical classification of pulmonary hypertension" J Am Coll Cardiol. (2013) 10.1016/j.jacc.2013.10.029
[25]
Ponikowski Eur Heart J. (2016) 10.1093/eurheartj/ehw128
[26]
Fine "A proportional hazards model for the subdistribution of a competing risk" J Am Stat Assoc. (1999) 10.1080/01621459.1999.10474144
[27]
Chambers "The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: thirty-sixth adult lung and heart-lung transplantation report-2019; focus theme: donor and recipient size match" J Heart Lung Transplant. (2019) 10.1016/j.healun.2019.08.001
[28]
Dimopoulos "Heart or heart-lung transplantation for patients with congenital heart disease in England" Heart. (2019) 10.1136/heartjnl-2018-313984
[29]
Callegari "Predictors of mortality in patients with Eisenmenger syndrome and admission to the lung transplantation waiting list" Monaldi Arch Chest Dis. (2004) 10.4081/monaldi.2004.681
[30]
De Meester "Lung transplant waiting list: differential outcome of type of end-stage lung disease, one year after registration" J Heart Lung Transplant. (1999) 10.1016/s1053-2498(99)00002-9
[31]
Hascoet "Pumpless lung assist as a bridge to medical therapy in a teenager with pulmonary arterial hypertension and partial anomalous pulmonary venous return" Can J Cardiol. (2020)
[32]
de Perrot "Outcome of patients with pulmonary arterial hypertension referred for lung transplantation: a 14-year single-center experience" J Thorac Cardiovasc Surg. (2012) 10.1016/j.jtcvs.2011.08.055
[33]
Christie "The registry of the International Society for Heart and Lung Transplantation: twenty-eighth adult lung and heart-lung transplant report–2011" J Heart Lung Transplant. (2011) 10.1016/j.healun.2011.08.004
[34]
Olland "Should we perform bilateral-lung or heart-lung transplantation for patients with pulmonary hypertension?" Interact Cardiovasc Thorac Surg. (2013) 10.1093/icvts/ivt111
[35]
Toyama "Two cases of bilateral lung transplantation combined with intracardiac repair and pulmonary artery replacement: perioperative managements based on the left ventricular function" J Anesth. (2015) 10.1007/s00540-015-2043-7
[36]
Wong "Outcomes of multi-organ transplant in adult patients with congenital heart disease" J Am Heart Assoc. (2019) 10.1161/jaha.119.014088
[37]
Cohen "Temporal trends and changing profile of adults with congenital heart disease undergoing heart transplantation" Eur Heart J. (2016) 10.1093/eurheartj/ehv628
[38]
Le Pavec "De-novo donor-specific anti-HLA antibodies 30 days after lung transplantation are associated with a worse outcome" J Heart Lung Transplant. (2016) 10.1016/j.healun.2016.05.020
[39]
Stehlik "The registry of the International Society for Heart and Lung Transplantation: 29th official adult heart transplant report–2012" J Heart Lung Transplant. (2012) 10.1016/j.healun.2012.08.002
[40]
Magnetta "Impact of the 2016 revision of US Pediatric Heart Allocation Policy on waitlist characteristics and outcomes" Am J Transplant. (2019) 10.1111/ajt.15567
[41]
Le rapport médical et scientifique de l’Agence de la biomédecine. https://www.agence-biomedecine.fr/annexes/bilan2017/donnees/organes/09-pediatrie/synthese.htm. Published 2017. Accessed January 10, 2020.
[42]
Moceri "Physiological differences between various types of Eisenmenger syndrome and relation to outcome" Int J Cardiol. (2015) 10.1016/j.ijcard.2014.11.100
[43]
Galiè "An overview of the 6th world symposium on pulmonary hypertension" Eur Respir J. (2019) 10.1183/13993003.02148-2018
[44]
Benza "Predicting survival in patients with pulmonary arterial hypertension: the REVEAL risk score calculator 2.0 and comparison with ESC/ERS-based risk assessment strategies" Chest. (2019) 10.1016/j.chest.2019.02.004
Metrics
9
Citations
44
References
Details
- Published
- Oct 01, 2021
- Vol/Issue
- 21(10)
- Pages
- 3388-3400
- License
- View
Authors
Cite This Article
Sébastien Hascoët, Margaux Pontailler, Jérome Le Pavec, et al. (2021). Transplantation for pulmonary arterial hypertension with congenital heart disease: Impact on outcomes of the current therapeutic approach including a high-priority allocation program. American Journal of Transplantation, 21(10), 3388-3400. https://doi.org/10.1111/ajt.16600
Related
You May Also Like
Diabetes Mellitus after Kidney Transplantation in the United States
Bertram L. Kasiske, Jon J. Snyder · 2003
1,046 citations
Banff ’05 Meeting Report: Differential Diagnosis of Chronic Allograft Injury and Elimination of Chronic Allograft Nephropathy (’CAN’)
K Solez, RB Colvin · 2007
897 citations
The Survival Benefit of Liver Transplantation
Robert M. Merion, Doulglas E. Schaubel · 2005
730 citations
COVID-19 in solid organ transplant recipients: Initial report from the US epicenter
Marcus R. Pereira, Sumit Mohan · 2020
671 citations
Evolution of Causes and Risk Factors for Mortality Post‐Liver Transplant: Results of the NIDDK Long‐Term Follow‐Up Study
K.D.S. Watt, R.A. Pedersen · 2010
669 citations